PRAX - Praxis Precision Medicines, Inc.
NEXT EARNINGS:
May 13, 2026
EPS Est: $-3.64
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$510.40
DETAILS
HIGH:
$843.00
LOW:
$83.00
MEDIAN:
$450.00
CONSENSUS:
$510.40
UPSIDE:
48.93%
Market Cap:
7.25B
Volume:
494,696
Avg Volume:
752,638
52 Week Range:
26.7-355.9999
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.87
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
116
IPO Date:
2020-10-16
EPS (TTM):
-13.48
P/E Ratio:
-21.87
Revenue (TTM):
N/A
Total Assets:
937.91M
Total Debt:
110,000
Cash & Equiv:
357.33M
Rev Growth (5Y):
249.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-37.1%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-3.50 | $-3.00 | -16.7% | — | $66667 | — |
| 2025-11-05 | $-3.36 | $-3.45 | +2.6% | — | $256090 | — |
| 2025-08-04 | $-3.31 | $-3.40 | +2.6% | — | $59440 | — |
| 2025-05-02 | $-3.29 | $-3.20 | -2.8% | — | $198800 | — |
| 2025-02-28 | $-2.94 | $-2.76 | -6.5% | $7.5M | $297880 | +2405.4% |
| 2024-11-06 | $-2.75 | $-2.01 | -36.8% | $302000 | $365000 | -17.3% |
| 2024-08-13 | $-1.74 | $-2.38 | +26.9% | $357000 | $830000 | -57.0% |
| 2024-05-13 | $-2.84 | $-2.01 | -41.3% | $431000 | $1.6M | -73.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 8.55M | 2.45M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (303.27M) | (182.82M) | (123.28M) | (214.03M) | (167.06M) | (61.82M) | (35.51M) | (26.54M) |
| EPS | -13.48 | -10.21 | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| Total Assets | 937.91M | 483.11M | 87.95M | 115.13M | 292.75M | 303.18M | 47.69M | 19.83M |
| Total Debt | 110,000 | 1.37M | 2.50M | 3.50M | 4.31M | 763,000 | 1.46M | 0 |
| Cash & Equivalents | 357.33M | 215.37M | 81.30M | 61.62M | 138.70M | 296.61M | 44.81M | 17.95M |
| Operating Cash Flow | (249.07M) | (131.76M) | (111.14M) | (185.04M) | (124.55M) | (52.62M) | (32.79M) | (20.72M) |
| Free Cash Flow | (249.12M) | (131.76M) | (111.19M) | (185.49M) | (125.60M) | (52.62M) | (32.89M) | (20.78M) |
| FCF per Share | -11.07 | -7.36 | -16.86 | -60.36 | -44.38 | -88.19 | -322.53 | -240.25 |
| Book Value | 878.14M | 445.45M | 69.67M | 76.11M | 250.81M | 287.46M | 40.11M | 14.68M |
| Cash & ST Investments | 599.33M | 392.57M | 81.30M | 100.49M | 275.91M | 296.61M | 44.81M | 17.95M |
| ROC Equity | -0.35 | -0.41 | -1.77 | -2.81 | -0.67 | -0.22 | -0.89 | -1.81 |